Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 14, 2013 - Issue 4
Submit an article Journal homepage
747
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

Miguel CasasDepartment of Psychiatry, Hospital Universitari Vall d’Hebron and Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, SpainCorrespondence[email protected]
,
Michael RöslerSaarland University Hospital, Neurocentre, D-66421 Homburg/Saar, Germany
,
J. J. Sandra KooijPsycho-Medical Programs, Program Adult ADHD, Den Haag, The Netherlands
,
Ylva GinsbergDepartment of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden and Karolinska Institutet Center of Neurodevelopmental Disorders, Stockholm, Sweden
,
Josep Antoni Ramos-QuirogaDepartment of Psychiatry, Hospital Universitari Vall d’Hebron, CIBERSAM, Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
,
Steffen HegerPrivate Practice Köln, Germany
,
Joris BerwaertsJohnson & Johnson Pharmaceutical Research & Development, Titusville, NJ, USA
,
Joachim DejonckheereSGS Life Science Services, Mechelen, Belgium
,
Erik van der VorstGlobal Clinical Operations, Janssen EMEA, Beerse, Belgium
&
Barbara SchäubleJanssen–Cilag Medical Affairs Europe, Middle East & Africa, Neuss, Germany
 show all
Pages 268-281 | Received 14 Feb 2011, Accepted 22 Jun 2011, Published online: 22 Nov 2011

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Doris Susanne Konrad-Bindl, Ursula Gresser & Barbara Maria Richartz. (2016) Changes in behavior as side effects in methylphenidate treatment: review of the literature. Neuropsychiatric Disease and Treatment 12, pages 2635-2647.
Read now
Louis S Matza, Mary K Devine, Virginia Sutton Haynes, Evan W Davies, Jacqueline M Kostelec, Foula Televantou & Jessica B Jordan. (2014) Health state utilities associated with adult attention-deficit/hyperactivity disorder. Patient Preference and Adherence 8, pages 997-1006.
Read now
Narong Maneeton, Benchalak Maneeton, Sirijit Suttajit, Jirayu Reungyos, Manit Srisurapanont & Stephen D Martin. (2014) Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD. Drug Design, Development and Therapy 8, pages 1685-1693.
Read now

Articles from other publishers (16)

Iman Idrees, Alessio Bellato, Samuele Cortese & Madeleine J. Groom. (2023) The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 144, pages 104968.
Crossref
Constantin-Cristian Topriceanu, James C. Moon, Gabriella Captur & Bhathika Perera. (2022) The use of attention-deficit hyperactivity disorder medications in cardiac disease. Frontiers in Neuroscience 16.
Crossref
Lenard A. Adler, Julie Adams, Jessica Madera-McDonough, Eva Kohegyi, Mary Hobart, Denise Chang, Mark Angelicola, Robert McQuade & Michael Liebowitz. (2022) Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 42:5, pages 429-439.
Crossref
Kim Boesen, Asger Sand Paludan-Müller, Peter C Gøtzsche & Karsten Juhl Jørgensen. (2022) Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2022:2.
Crossref
Wolfgang Retz. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 2465 2486 .
Wolfgang Retz. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 23 .
Jesse Elliott, Amy Johnston, Don Husereau, Shannon E. Kelly, Caroline Eagles, Alice Charach, Shu-Ching Hsieh, Zemin Bai, Alomgir Hossain, Becky Skidmore, Eva Tsakonas, Dagmara Chojecki, Muhammad Mamdani & George A. Wells. (2020) Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLOS ONE 15:10, pages e0240584.
Crossref
Camila B. Villas-Boas, Danielly Chierrito, Fernando Fernandez-Llimos, Fernanda S. Tonin & Andréia C.C. Sanches. (2019) Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder. International Clinical Psychopharmacology 34:2, pages 57-64.
Crossref
Matej Stuhec, Petar Lukić & Igor Locatelli. (2018) Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis. Annals of Pharmacotherapy 53:2, pages 121-133.
Crossref
David R. Coghill, Tobias Banaschewski, César Soutullo, Matthew G. Cottingham & Alessandro Zuddas. (2017) Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry 26:11, pages 1283-1307.
Crossref
Ming-Horng Tsai, Jen-Fu Hsu & Yu-Shu Huang. (2016) Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management. Current Psychiatry Reports 18:8.
Crossref
Katrien De Bruyckere, Chris Bushe, Christoph Bartel, Lovisa Berggren, Cornelis C. Kan & Ralf W. Dittmann. (2016) Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database. CNS Drugs 30:6, pages 541-558.
Crossref
M. Fridman, P.S. Hodgkins, J.S. Kahle & M.H. Erder. (2020) Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysis. European Psychiatry 30:4, pages 521-527.
Crossref
Allan Hvolby. (2014) Associations of sleep disturbance with ADHD: implications for treatment. ADHD Attention Deficit and Hyperactivity Disorders 7:1, pages 1-18.
Crossref
Martin A. Katzman & Tia Sternat. (2014) A Review of OROS Methylphenidate (Concerta®) in the Treatment of Attention-Deficit/Hyperactivity Disorder. CNS Drugs 28:11, pages 1005-1033.
Crossref
Xavier Castells, Ruth Cunill & Dolors Capellà. (2012) Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials. European Journal of Clinical Pharmacology 69:3, pages 347-356.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.